Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: Biological implications

Virology

Volumn 405, Issue 2, 2010, Pages 556-567

  Wu, Tiyun ^a   Datta, Siddhartha A K ^b   Mitra, Mithun ^a   Gorelick, Robert J ^c   Rein, Alan ^b   Levin, Judith G ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SAIC FREDERICK INC   (United States)

Author keywords

Capsid protein; Gag; HIV 1; Minus strand transfer; Nucleic acid chaperone; Nucleic acid driven multimerization; Nucleocapsid protein; Retrovirus; Reverse transcription

Indexed keywords

CHAPERONE; GAG PROTEIN; NUCLEIC ACID; NUCLEOCAPSID PROTEIN; VIRUS DNA;

ARTICLE; DNA SYNTHESIS; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION;

CELL LINE; DNA, VIRAL; FLUORESCENCE POLARIZATION; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV-1; HUMANS; MOLECULAR CHAPERONES; NUCLEIC ACID CONFORMATION; PROTEIN MULTIMERIZATION; REVERSE TRANSCRIPTION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

EID: 77955657763     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.06.042     Document Type: Article

References (79)

1. Adachi A., Gendelman H.E., Koenig S., Folks T., Willey R., Rabson A., Martin M.A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 1986, 59(2):284-291.
2. Adamson C.S., Freed E.O. Human immunodeficiency virus type 1 assembly, release, and maturation. Adv. Pharmacol. 2007, 55:347-387.
3. Bampi C., Jacquenet S., Lener D., Décimo D., Darlix J.L. The chaperoning and assistance roles of the HIV-1 nucleocapsid protein in proviral DNA synthesis and maintenance. Curr. HIV Res. 2004, 2(1):79-92.
4. Basu V.P., Song M., Gao L., Rigby S.T., Hanson M.N., Bambara R.A. Strand transfer events during HIV-1 reverse transcription. Virus Res. 2008, 134(1-2):19-38.
5. Beltz H., Clauss C., Piémont E., Ficheux D., Gorelick R.J., Roques B., Gabus C., Darlix J.-L., de Rocquigny H., Mély Y. Structural determinants of HIV-1 nucleocapsid protein for cTAR DNA binding and destabilization, and correlation with inhibition of self-primed DNA synthesis. J. Mol. Biol. 2005, 348(5):1113-1126.
6. Bishop K.N., Verma M., Kim E.Y., Wolinsky S.M., Malim M.H. APOBEC3G inhibits elongation of HIV-1 reverse transcripts. PLoS Pathog. 2008, 4(12):e1000231.
7. 2+ fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA. J. Virol. 2003, 77(2):1469-1480.
8. Campbell S., Rein A. In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J. Virol. 1999, 73(3):2270-2279.
9. Campbell S., Vogt V.M. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J. Virol. 1995, 69(10):6487-6497.
10. Carteau S., Gorelick R.J., Bushman F.D. Coupled integration of human immunodeficiency virus type 1 cDNA ends by purified integrase in vitro: stimulation by the viral nucleocapsid protein. J. Virol. 1999, 73(8):6670-6679.
11. Lys to human immunodeficiency virus type 1 genomic RNA. J. Virol. 1999, 73(5):4485-4488.
12. Lys genomic placement and the initiation step of reverse transcription in human immunodeficiency virus type 1. J. Virol. 2000, 74(22):10796-10800.
13. Chan B., Weidemaier K., Yip W.-T., Barbara P.F., Musier-Forsyth K. Intra-tRNA distance measurements for nucleocapsid protein-dependent tRNA unwinding during priming of HIV reverse transcription. Proc. Natl. Acad. Sci. U.S.A. 1999, 96(2):459-464.
14. Checkley M.A., Luttge B.G., Soheilian F., Nagashima K., Freed E.O. The capsid-spacer peptide 1 Gag processing intermediate is a dominant-negative inhibitor of HIV-1 maturation. Virology 2010, 400(1):137-144.
15. Chukkapalli V., Oh S.J., Ono A. Opposing mechanisms involving RNA and lipids regulate HIV-1 Gag membrane binding through the highly basic region of the matrix domain. Proc. Natl. Acad. Sci. U.S.A. 2010, 107(4):1600-1605.
16. Cruceanu M., Gorelick R.J., Musier-Forsyth K., Rouzina I., Williams M.C. Rapid kinetics of protein-nucleic acid interaction is a major component of HIV-1 nucleocapsid protein's nucleic acid chaperone function. J. Mol. Biol. 2006, 363(5):867-877.
17. Cruceanu M., Urbaneja M.A., Hixson C.V., Johnson D.G., Datta S.A., Fivash M.J., Stephen A.G., Fisher R.J., Gorelick R.J., Casas-Finet J.R., Rein A., Rouzina I., Williams M.C. Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteins. Nucleic Acids Res. 2006, 34(2):593-605.
18. Darlix J.-L., Gabus C., Nugeyre M.T., Clavel F., Barré-Sinoussi F. Cis elements and trans-acting factors involved in the RNA dimerization of the human immunodeficiency virus HIV-1. J. Mol. Biol. 1990, 216(3):689-699.
19. Darlix J.-L., Lapadat-Tapolsky M., de Rocquigny H., Roques B.P. First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J. Mol. Biol. 1995, 254(4):523-537.
20. Darlix J.-L., Garrido J.L., Morellet N., Mély Y., de Rocquigny H. Properties, functions, and drug targeting of the multifunctional nucleocapsid protein of the human immunodeficiency virus. Adv. Pharmacol. 2007, 55:299-346.
21. Datta S.A.K., Rein A. Preparation of recombinant HIV-1 Gag protein and assembly of virus-like particles in vitro. Meth. Mol. Biol. 2009, 485:197-208.
22. Datta S.A.K., Curtis J.E., Ratcliff W., Clark P.K., Crist R.M., Lebowitz J., Krueger S., Rein A. Conformation of the HIV-1 Gag protein in solution. J. Mol. Biol. 2007, 365(3):812-824.
23. Datta S.A.K., Zhao Z., Clark P.K., Tarasov S., Alexandratos J.N., Campbell S.J., Kvaratskhelia M., Lebowitz J., Rein A. Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch. J. Mol. Biol. 2007, 365(3):799-811.
24. Driscoll M.D., Hughes S.H. Human immunodeficiency virus type 1 nucleocapsid protein can prevent self-priming of minus-strand strong stop DNA by promoting the annealing of short oligonucleotides to hairpin sequences. J. Virol. 2000, 74(19):8785-8792.
25. Dussupt V., Javid M.P., Abou-Jaoude G., Jadwin J.A., de La Cruz J., Nagashima K., Bouamr F. The nucleocapsid region of HIV-1 Gag cooperates with the PTAP and LYPXnL late domains to recruit the cellular machinery necessary for viral budding. PLoS Pathog. 2009, 5(3):e1000339.
26. Fäcke M., Janetzko A., Shoeman R.L., Kräusslich H.-G. A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum. J. Virol. 1993, 67(8):4972-4980.
27. Feng Y.X., Copeland T.D., Henderson L.E., Gorelick R.J., Bosche W.J., Levin J.G., Rein A. HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro. Proc. Natl. Acad. Sci. U.S.A. 1996, 93(15):7577-7581.
28. Feng Y.-X., Campbell S., Harvin D., Ehresmann B., Ehresmann C., Rein A. The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site. J. Virol. 1999, 73(5):4251-4256.
29. Freed E.O. HIV-1 Gag proteins: diverse functions in the virus life cycle. Virology 1998, 251(1):1-15.
30. Gamble T.R., Yoo S., Vajdos F.F., von Schwedler U.K., Worthylake D.K., Wang H., McCutcheon J.P., Sundquist W.I., Hill C.P. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science 1997, 278(5339):849-853.
31. Graham F.L., van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 1973, 52(2):456-467.
32. Gross I., Hohenberg H., Wilk T., Wiegers K., Grättinger M., Müller B., Fuller S., Kräusslich H.-G. A conformational switch controlling HIV-1 morphogenesis. EMBO J. 2000, 19(1):103-113.
33. Guo J., Wu W., Yuan Z.Y., Post K., Crouch R.J., Levin J.G. Defects in primer-template binding, processive DNA synthesis, and RNase H activity associated with chimeric reverse transcriptases having the murine leukemia virus polymerase domain joined to Escherichia coli RNase H. Biochemistry 1995, 34(15):5018-5029.
34. Guo J., Henderson L.E., Bess J., Kane B., Levin J.G. Human immunodeficiency virus type 1 nucleocapsid protein promotes efficient strand transfer and specific viral DNA synthesis by inhibiting TAR-dependent self-priming from minus-strand strong-stop DNA. J. Virol. 1997, 71(7):5178-5188.
35. Guo J., Wu T., Anderson J., Kane B.F., Johnson D.G., Gorelick R.J., Henderson L.E., Levin J.G. Zinc finger structures in the human immunodeficiency virus type 1 nucleocapsid protein facilitate efficient minus- and plus-strand transfer. J. Virol. 2000, 74(19):8980-8988.
36. Lys annealing to viral RNA in human immunodeficiency virus type 1. J. Virol. 2009, 83(16):8099-8107.
37. Lys,3 structural changes but are not critical for primer/template annealing. J. Mol. Biol. 2001, 312(5):985-997.
38. Heilman-Miller S.L., Wu T., Levin J.G. Alteration of nucleic acid structure and stability modulates the efficiency of minus-strand transfer mediated by the HIV-1 nucleocapsid protein. J. Biol. Chem. 2004, 279(42):44154-44165.
39. Henderson L.E., Bowers M.A., Sowder R.C., Serabyn S.A., Johnson D.G., Bess J.W., Arthur L.O., Bryant D.K., Fenselau C. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences. J. Virol. 1992, 66(4):1856-1865.
40. Lys on the viral genome exists in unextended and two-base extended forms within mature human immunodeficiency virus type 1. J. Virol. 1997, 71(1):726-728.
41. Iwatani Y., Chan D.S., Wang F., Maynard K.S., Sugiura W., Gronenborn A.M., Rouzina I., Williams M.C., Musier-Forsyth K., Levin J.G. Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G. Nucleic Acids Res. 2007, 35(21):7096-7108.
42. Kaplan A.H., Krogstad P., Kempf D.J., Norbeck D.W., Swanstrom R. Human immunodeficiency virus type 1 virions composed of unprocessed Gag and Gag-Pol precursors are capable of reverse transcribing viral genomic RNA. Antimicrob. Agents Chemother. 1994, 38(12):2929-2933.
43. Lys packaging complex in HIV-1. Int. J. Biochem. Cell Biol. 2004, 36(9):1776-1786.
44. Lapadat-Tapolsky M., Gabus C., Rau M., Darlix J.-L. Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability. J. Mol. Biol. 1997, 268(2):250-260.
45. Lee S.-K., Harris J., Swanstrom R. A strongly transdominant mutation in the human immunodeficiency virus type 1 gag gene defines an Achilles heel in the virus life cycle. J. Virol. 2009, 83(17):8536-8543.
46. Levin J.G., Guo J., Rouzina I., Musier-Forsyth K. Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: critical role in reverse transcription and molecular mechanism. Prog. Nucleic Acid Res. Mol. Biol. 2005, 80:217-286.
47. Liang C., Rong L., Laughrea M., Kleiman L., Wainberg M.A. Compensatory point mutations in the human immunodeficiency virus type 1 Gag region that are distal from deletion mutations in the dimerization initiation site can restore viral replication. J. Virol. 1998, 72(8):6629-6636.
48. Müller B., Anders M., Akiyama H., Welsch S., Glass B., Nikovics K., Clavel F., Tervo H.M., Keppler O.T., Kraüsslich H.-G. HIV-1 Gag processing intermediates trans-dominantly interfere with HIV-1 infectivity. J. Biol. Chem. 2009, 284(43):29692-29703.
49. Muriaux D., De Rocquigny H., Roques B.P., Paoletti J. NCp7 activates HIV-1 Lai RNA dimerization by converting a transient loop-loop complex into a stable dimer. J. Biol. Chem. 1996, 271(52):33686-33692.
50. Ott D.E., Coren L.V., Johnson D.G., Kane B.P., Sowder R.C., Kim Y.D., Fisher R.J., Zhou X.Z., Lu K.P., Henderson L.E. Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology 2000, 266(1):42-51.
51. Popov S., Popova E., Inoue M., Göttlinger H.G. Divergent Bro1 domains share the capacity to bind human immunodeficiency virus type 1 nucleocapsid and to enhance virus-like particle production. J. Virol. 2009, 83(14):7185-7193.
52. Prats A.C., Sarih L., Gabus C., Litvak S., Keith G., Darlix J.-L. Small finger protein of avian and murine retroviruses has nucleic acid annealing activity and positions the replication primer tRNA onto genomic RNA. EMBO J. 1988, 7(6):1777-1783.
53. Qualley D.F., Stewart-Maynard K.M., Wang F., Mitra M., Gorelick R.J., Rouzina I., Williams M.C., Musier-Forsyth K. C-terminal domain modulates the nucleic acid chaperone activity of human T-cell leukemia virus type 1 nucleocapsid protein via an electrostatic mechanism. J. Biol. Chem. 2010, 285(1):295-307.
54. Rajkowitsch L., Chen D., Stampfl S., Semrad K., Waldsich C., Mayer O., Jantsch M.F., Konrat R., Bläsi U., Schroeder R. RNA chaperones, RNA annealers and RNA helicases. RNA Biol. 2007, 4(3):118-130.
55. Ratner L., Haseltine W., Patarca R., Livak K.J., Starcich B., Josephs S.F., Doran E.R., Rafalski J.A., Whitehorn E.A., Baumeister K., et al. Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 1985, 313(6000):277-284.
56. Rein A., Henderson L.E., Levin J.G. Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. Trends Biochem. Sci. 1998, 23(8):297-301.
57. Gag multimerization. J. Biol. Chem. 2004, 279(38):39886-39894.
58. Lys annealing and exhibits multimerization-induced inhibition of reverse transcription. J. Biol. Chem. 2005, 280(17):17488-17496.
59. Rong L., Liang C., Hsu M., Kleiman L., Petitjean P., de Rocquigny H., Roques B.P., Wainberg M.A. Roles of the human immunodeficiency virus type 1 nucleocapsid protein in annealing and initiation versus elongation in reverse transcription of viral negative-strand strong-stop DNA. J. Virol. 1998, 72(11):9353-9358.
60. Rulli S.J., Muriaux D., Nagashima K., Mirro J., Oshima M., Baumann J.G., Rein A. Mutant murine leukemia virus Gag proteins lacking proline at the N-terminus of the capsid domain block infectivity in virions containing wild-type Gag. Virology 2006, 347(2):364-371.
61. Shkriabai N., Datta S.A.K., Zhao Z., Hess S., Rein A., Kvaratskhelia M. Interactions of HIV-1 Gag with assembly cofactors. Biochemistry 2006, 45(13):4077-4083.
62. Stephen A.G., Datta S.A., Worthy K.M., Bindu L., Fivash M.J., Turner K.B., Fabris D., Rein A., Fisher R.J. Measuring the binding stoichiometry of HIV-1 Gag to very-low-density oligonucleotide surfaces using surface plasmon resonance spectroscopy. J. Biomol. Tech. 2007, 18(4):259-266.
63. Swanstrom R., Wills J.W. Synthesis, assembly, and processing of viral proteins. Retroviruses 1997, 263-334. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y. J.M. Coffin, S.H. Hughes, H.E. Varmus (Eds.).
64. Tang S., Murakami T., Agresta B.E., Campbell S., Freed E.O., Levin J.G. Human immunodeficiency virus type 1N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells. J. Virol. 2001, 75(19):9357-9366.
65. Thomas J.A., Gorelick R.J. Nucleocapsid protein function in early infection processes. Virus Res. 2008, 134(1-2):39-63.
66. Thomas J.A., Gagliardi T.D., Alvord W.G., Lubomirski M., Bosche W.J., Gorelick R.J. Human immunodeficiency virus type 1 nucleocapsid zinc-finger mutations cause defects in reverse transcription and integration. Virology 2006, 353(1):41-51.
67. Thomas J.A., Bosche W.J., Shatzer T.L., Johnson D.G., Gorelick R.J. Mutations in human immunodeficiency virus type 1 nucleocapsid protein zinc fingers cause premature reverse transcription. J. Virol. 2008, 82(19):9318-9328.
68. Lys with HIV-1 nucleocapsid protein. J. Mol. Biol. 2001, 306(3):443-454.
69. Tsuchihashi Z., Brown P.O. DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 1994, 68(9):5863-5870.
70. Turner B.G., Summers M.F. Structural biology of HIV. J. Mol. Biol. 1999, 285(1):1-32.
71. Vogt V.M. Retroviral virions and genomes. Retroviruses 1997, 27-69. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N. Y. J.M. Coffin, S.H. Hughes, H.E. Varmus (Eds.).
72. von Schwedler U.K., Stemmler T.L., Klishko V.Y., Li S., Albertine K.H., Davis D.R., Sundquist W.I. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J. 1998, 17(6):1555-1568.
73. von Schwedler U.K., Stray K.M., Garrus J.E., Sundquist W.I. Functional surfaces of the human immunodeficiency virus type 1 capsid protein. J. Virol. 2003, 77(9):5439-5450.
74. Williams M.C., Rouzina I., McCauley M.J. Peeling back the mystery of DNA overstretching. Proc. Natl. Acad. Sci. U.S.A. 2009, 106(43):18047-18048.
75. Wu T., Heilman-Miller S.L., Levin J.G. Effects of nucleic acid local structure and magnesium ions on minus-strand transfer mediated by the nucleic acid chaperone activity of HIV-1 nucleocapsid protein. Nucleic Acids Res. 2007, 35(12):3974-3987.
76. Wu W., Henderson L.E., Copeland T.D., Gorelick R.J., Bosche W.J., Rein A., Levin J.G. Human immunodeficiency virus 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract. J. Virol. 1996, 70(10):7132-7142.
77. Wyma D.J., Jiang J., Shi J., Zhou J., Lineberger J.E., Miller M.D., Aiken C. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail. J. Virol. 2004, 78(7):3429-3435.
78. Yoo S., Myszka D.G., Yeh C., McMurray M., Hill C.P., Sundquist W.I. Molecular recognition in the HIV-1 capsid/cyclophilin A complex. J. Mol. Biol. 1997, 269(5):780-795.
79. Zúñiga S., Cruz J.L.G., Sola I., Mateos-Gómez P.A., Palacio L., Enjuanes L. Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription. J. Virol. 2010, 84(4):2169-2175.